We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
Cap. Flow
+$404M
Cap. Flow %
6.55%
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313

Top Buys

Rank Stock Value
1
ENDP
Endo International plc
ENDP
+$197M
2
AGN
Allergan plc
AGN
+$135M
3
BHC icon
Bausch Health
BHC
+$129M
4
CVS icon
CVS Health
CVS
+$107M
5
MCK icon
McKesson
MCK
+$94.3M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$286M
2
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$225M
3
GILD icon
Gilead Sciences
GILD
+$86.1M
4
PRGO icon
Perrigo
PRGO
+$79.4M
5
CAH icon
Cardinal Health
CAH
+$74.8M

Sector Composition

Rank Sector Weight
1 Healthcare 53.16%
2 Consumer Discretionary 5.06%
3 Energy 4.01%
4 Utilities 3.23%
5 Financials 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRC
951
DELISTED
MRC Global
MRC
– –
-73,869
Closed -$2.38M
MT icon
952
ArcelorMittal
MT
$53.5B
– –
-114,450
Closed -$4.67M
NICE icon
953
Nice
NICE
$5.93B
– –
-16,448
Closed -$674K
NIE
954
Virtus Equity & Convertible Income Fund
NIE
$720M
– –
-21,794
Closed -$426K
NLY icon
955
Annaly Capital Management
NLY
$17.3B
– –
-3,288
Closed -$131K
NOC icon
956
Northrop Grumman
NOC
$78.6B
– –
-1,989
Closed -$228K
NOW icon
957
ServiceNow
NOW
$120B
– –
-104,905
Closed -$1.18M
NRO
958
Neuberger Real Estate Securities Income Fund Inc
NRO
$191M
– –
-148,319
Closed -$614K
NSC icon
959
Norfolk Southern
NSC
$75.6B
– –
-4,617
Closed -$429K
NUE icon
960
Nucor
NUE
$57.6B
– –
-8,700
Closed -$464K
NUS icon
961
Nu Skin
NUS
$257M
– –
-146,205
Closed -$20.2M
NVO
962
Novo Nordisk
NVO
$207B
– –
-90,860
Closed -$1.68M
NVRI icon
963
Enviri
NVRI
$637M
– –
-13,500
Closed -$378K
NZF icon
964
Nuveen Municipal Credit Income Fund
NZF
$2.41B
– –
-61,471
Closed -$759K
OCSL icon
965
Oaktree Specialty Lending
OCSL
$1.04B
– –
-5,025
Closed -$139K
ODFL icon
966
Old Dominion Freight Line
ODFL
$44.3B
– –
-73,437
Closed -$1.3M
OFIX icon
967
Orthofix Medical
OFIX
$497M
– –
-130,100
Closed -$2.97M
OGE icon
968
OGE Energy
OGE
$9.93B
– –
-24,163
Closed -$819K
OIH icon
969
VanEck Oil Services ETF
OIH
$1.88B
– –
-7,821
Closed -$7.52M
OMC icon
970
Omnicom Group
OMC
$22.2B
– –
-3,849
Closed -$287K
ACH
971
Accendra Health
ACH
$244M
– –
-30,900
Closed -$1.13M
ORCL icon
972
Oracle
ORCL
$393B
– –
-6,233
Closed -$238K
OSK icon
973
Oshkosh
OSK
$9.06B
– –
-94,780
Closed -$4.78M
OVV icon
974
Ovintiv
OVV
$17B
– –
-30,760
Closed -$2.78M
PBH icon
975
Prestige Consumer Healthcare
PBH
$2.44B
– –
-78,699
Closed -$2.82M
37 38
39
40 41

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q1 2014 Portfolio in Review

As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.

On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.

  • Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
  • Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
  • Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
  • Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
  • Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
  • Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
  • Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.

Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.